Within a few months, coronavirus disease 2019 (COVID-19) has become a pandemic with more than 2 million patients infected and a high mortality rate. Early detection of COVID-19 in oncologic patients is crucial in order to rapidly apply isolation measures and avoid nosocomial spread. However, early diagnosis may be challenging, especially in cancer patients under treatment with immunotherapy as drug-induced pneumonitis can present similar clinical and radiological features. We describe the findings of a SARS-CoV-2 infection on PET/CT with F-FDG in a 51-year-old man with metastatic renal cell carcinoma under treatment with nivolumab.
Clinical nuclear medicine. 2020 Jun 08 [Epub ahead of print]
Carlos Artigas, Marc Lemort, Fabienne Mestrez, Thierry Gil, Patrick Flamen
From the Departments of Nuclear Medicine., Radiology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels., Department of Nephrology-Dialysis, University Hospital (CHU) Ambroise Paré, Mons., Department of Oncology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.